Preliminary data published in June 2023 also suggests that GLP-1 drugs 'could modulate crucial pathways in the pathogenesis of inflammatory bowel disease (IBD), such as chronic inflammation circuits, intestinal tight junctions, and gut microbiome dysbiosis, setting the stage for human trials to investigate the role of these agents in the treatment of IBD among people with or without diabetes and obesity' (Arvanitakis, Theocharis, Popovic
Maturitas 82 , 5055 (2015)
Signs include swelling of the face, lips, tongue, or throat, difficulty breathing, and severe rash
The detection of significant temporal trends coupled with detailed spatial investigation of disasters provides a comprehensive view of Kentucky disasters that may inform future research into their forcing mechanisms